2BECAPITAL LIMITED
Company number 13765965 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
2BECAPITAL LIMITED - Analysis Report
Company Number: 13765965
Analysis Date: 2025-07-29 15:54 UTC
Financial Health Assessment of 2BECAPITAL LIMITED
1. Financial Health Score: D
Explanation:
2BECAPITAL LIMITED currently exhibits signs of financial distress, reflected by net current liabilities and negative shareholders’ funds as of the latest financial year-end. The company’s working capital position has deteriorated significantly compared to previous years, indicating liquidity challenges. While the directors express confidence in going concern based on support from related parties, the core financial metrics reveal symptoms that warrant close monitoring and remedial action.
2. Key Vital Signs
| Metric | 2023 (£) | 2022 (£) | Interpretation |
|---|---|---|---|
| Current Assets | 1,164,841 | 311,257 | Increased substantially, mainly debtors; indicates growth in amounts owed to company. |
| Cash | 582 | 0 | Minimal cash on hand, indicating poor immediate liquidity. |
| Debtors | 1,164,259 | 311,257 | Large increase in receivables; risk of collection problems or extended credit terms. |
| Current Liabilities | 1,390,846 | 308,762 | Increased drastically, exceeding current assets; high short-term obligations. |
| Net Current Assets | -226,005 | 2,495 | Negative working capital; red flag for short-term liquidity and operational stress. |
| Shareholders’ Funds | -226,105 | 2,495 | Negative equity position; indicates accumulated losses eroding capital base. |
| Number of Employees | 2 | 2 | Stable small workforce; suggests low fixed costs but limited operational scale. |
| Profit/Loss for the year | Loss of £228,500 | N/A | Material loss reflected in reserves; impacts net assets and financial stability. |
3. Diagnosis
Symptoms Analysis:
- Liquidity Strain: The company's current liabilities have outpaced current assets sharply, resulting in negative net current assets. This symptom is analogous to a patient whose pulse is weak and irregular—cash and liquid assets are insufficient to meet imminent obligations, posing a risk of default if support is withdrawn.
- Receivables Concentration: A significant increase in debtors suggests revenue growth or extended credit terms but raises concerns about the collectability of these amounts. This could be a symptom of "credit risk fever," where money owed is tied up and not converting into cash quickly enough.
- Negative Equity: The erosion of shareholders' funds into negative territory is a serious symptom akin to "financial anemia," where the company’s net worth is below zero, indicating accumulated losses or sustained operational deficits. This reduces the company’s cushioning against financial shocks.
- Going Concern: Directors note reliance on working capital loans from connected companies to continue operations, which is a "life support system" for the business. While this provides temporary stability, it is not a sustainable long-term cure.
Underlying Issues:
- The company appears to be in the early growth or investment phase, given its recent incorporation (2021) and increasing receivables, but is currently financially fragile.
- The mismatch between current liabilities and liquid assets signals a potential cash flow crisis unless the company can either collect receivables faster or secure additional funding.
- The loss and negative equity highlight that operations are currently not profitable or cash-generative, requiring strategic intervention.
4. Recommendations
Immediate Actions:
- Improve Cash Management: Prioritize accelerating debtor collections and closely monitor credit risk to convert receivables into cash more quickly. Consider tighter credit controls or factoring arrangements.
- Negotiate with Creditors: Engage with suppliers and creditors to extend payment terms, easing short-term liquidity pressure.
- Access Additional Funding: Secure further working capital loans or equity injections from connected parties or external investors to stabilize the balance sheet and cover short-term obligations.
Medium to Long Term:
- Operational Review: Evaluate the company’s business model and revenue streams to identify paths to profitability and sustainable cash flow generation.
- Cost Control: Maintain tight control on operating costs given the small workforce but explore efficiencies to reduce losses.
- Financial Monitoring: Implement regular financial health check-ups, focusing on liquidity ratios (current ratio, quick ratio), cash flow forecasts, and equity position to detect and address symptoms early.
- Transparency and Reporting: Although exempt from audit, consider voluntary external review or enhanced internal controls to improve stakeholder confidence.
Executive Summary
Sign in to generate a free AI analysis of this company — no password needed, just an email link.